OROPHARYNX SQUAMOUS CELL CARCINOMA
Clinical trials for OROPHARYNX SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNX SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OROPHARYNX SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests new combo for Tough-to-Treat head & neck cancers
Disease control CompletedThis early-stage study tested the safety of combining two immunotherapy drugs, IRX-2 and durvalumab, for patients with incurable head and neck cancer. The main goal was to find the highest dose patients could tolerate without severe side effects and to see if the treatment increa…
Matched conditions: OROPHARYNX SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Immunotherapy boost tested for tough throat cancers
Disease control CompletedThis study tested whether adding the immunotherapy drug nivolumab to the standard treatment of radiation and chemotherapy could better control high-risk HPV-related throat cancer and keep it from returning. It involved 26 adults with advanced-stage cancer of the tonsils or base o…
Matched conditions: OROPHARYNX SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Virtual surgery planning tested to improve life after jaw cancer
Symptom relief CompletedThis study compared two methods for planning jaw reconstruction surgery in patients with oral or throat cancer. It tested whether using advanced 3D virtual planning before surgery leads to better quality of life outcomes than traditional planning. The main goal was to see if pati…
Matched conditions: OROPHARYNX SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: UNICANCER • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
Patch tested to help cancer patients speak and swallow after surgery
Symptom relief CompletedThis study looked at whether using a collagen patch during surgery for oral or throat cancer helps patients recover their ability to swallow and speak. 33 patients answered questionnaires about their swallowing and voice before surgery, and again at 1 and 6 months after. The goal…
Matched conditions: OROPHARYNX SQUAMOUS CELL CARCINOMA
Sponsor: SAYAH Charline • Aim: Symptom relief
Last updated Mar 24, 2026 12:03 UTC